521225 Sigma-AldrichPDGF, BB Homodimer, Human, Recombinant, E. coli
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Purity |
|---|
| ≥95% by SDS-PAGE |
| Product Information | |
|---|---|
| Form | Lyophilized |
| Formulation | Lyophilized from a sterile-filtered solution, carrier free. |
| Quality Segment | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Biological activity | ED₅₀ = 1-5 ng/ml as determined by the dose dependent proliferation of BALB/c 3T3 cells |
| Purity | ≥95% by SDS-PAGE |
| Physicochemical Information | |
|---|---|
| Contaminants | Endotoxin: ≤1 ng/µg PDGF-BB |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade ITEM Number | |
|---|---|
| Catalogue Number | GTIN |
| 521225 | 0 |
Documentation
PDGF, BB Homodimer, Human, Recombinant, E. coli SDS
| Title |
|---|
PDGF, BB Homodimer, Human, Recombinant, E. coli Certificates of Analysis
| Title | Lot Number |
|---|---|
| 521225 |
References
| Reference overview |
|---|
| Abedi, H., et al. 1998. FEBS Lett. 427, 209. Abboud, H.E., et al. 1994. J. Cell Physiol. 158, 140. Westermark, B., and Heldin, C.-H. 1991. Cancer Res. 51, 5087. Raines, E.W., et al. 1985. Methods Enzymol. 109, 749. Johnson, A., et al. 1984. EMBO J. 3, 921. |



